IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 78 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 3.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $16,000 | -27.3% | 11,986 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $22,000 | +37.5% | 11,986 | +58.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | +6.7% | 7,586 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $15,000 | +15.4% | 7,586 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $13,000 | -31.6% | 7,586 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $19,000 | – | 7,586 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,550,000 | $16,437,000 | 2.17% |
| Ghost Tree Capital, LLC | 550,000 | $2,547,000 | 1.57% |
| HealthCor Management, L.P. | 3,350,000 | $15,511,000 | 0.94% |
| EAM Investors, LLC | 541,969 | $2,509,000 | 0.45% |
| Baker Brothers Advisors | 3,171,765 | $14,685,000 | 0.21% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 405,729 | $1,878,000 | 0.16% |
| Spark Investment Management LLC | 169,000 | $779,000 | 0.14% |
| CARL DOMINO INC | 50,137 | $232,000 | 0.13% |
| NATIXIS | 3,149,816 | $14,583,000 | 0.12% |
| HOLLENCREST CAPITAL MANAGEMENT | 132,000 | $611,000 | 0.10% |